Literature DB >> 1318766

Lung cancer.

R Souhami1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318766      PMCID: PMC1881861          DOI: 10.1136/bmj.304.6837.1298

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  17 in total

Review 1.  Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture.

Authors:  R Doll
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer.

Authors:  M G Kris; R J Gralla; N Martini; L V Stampleman; M T Burke
Journal:  Surg Clin North Am       Date:  1987-10       Impact factor: 2.741

3.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

Authors:  M C Perry; W L Eaton; K J Propert; J H Ware; B Zimmer; A P Chahinian; A Skarin; R W Carey; H Kreisman; C Faulkner
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

4.  Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.

Authors:  R I Linnoila; J L Mulshine; S M Steinberg; K Funa; M J Matthews; J D Cotelingam; A F Gazdar
Journal:  Am J Clin Pathol       Date:  1988-12       Impact factor: 2.493

5.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.

Authors:  R O Dillman; S L Seagren; K J Propert; J Guerra; W L Eaton; M C Perry; R W Carey; E F Frei; M R Green
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

Review 6.  Lung cancer biology.

Authors:  D N Carney; L De Leij
Journal:  Semin Oncol       Date:  1988-06       Impact factor: 4.929

7.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

8.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

Authors:  E Rapp; J L Pater; A Willan; Y Cormier; N Murray; W K Evans; D I Hodson; D A Clark; R Feld; A M Arnold
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

9.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

Authors:  F Cuttitta; D N Carney; J Mulshine; T W Moody; J Fedorko; A Fischler; J D Minna
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  2 in total

1.  Treating small cell lung cancer.

Authors:  F E Von Eyben
Journal:  BMJ       Date:  1992-07-04

2.  p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.

Authors:  C Walker; L J Robertson; M W Myskow; N Pendleton; G R Dixon
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.